These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32421150)

  • 1. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times.
    Collins FS; Stoffels P
    JAMA; 2020 Jun; 323(24):2455-2457. PubMed ID: 32421150
    [No Abstract]   [Full Text] [Related]  

  • 2. The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
    Bollyky TJ; Gostin LO; Hamburg MA
    JAMA; 2020 Jun; 323(24):2462-2463. PubMed ID: 32379268
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    Thomson K; Nachlis H
    JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
    [No Abstract]   [Full Text] [Related]  

  • 4. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.
    Sempowski GD; Saunders KO; Acharya P; Wiehe KJ; Haynes BF
    Cell; 2020 Jun; 181(7):1458-1463. PubMed ID: 32492407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beat COVID-19 through innovation.
    Azoulay P; Jones B
    Science; 2020 May; 368(6491):553. PubMed ID: 32381693
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2: a time for clear and immediate action.
    Poland GA
    Lancet Infect Dis; 2020 May; 20(5):531-532. PubMed ID: 32243818
    [No Abstract]   [Full Text] [Related]  

  • 7. We're on our own.
    Thorp HH
    Sci Transl Med; 2020 Sep; 12(562):. PubMed ID: 32887789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
    Avorn J; Kesselheim AS
    N Engl J Med; 2020 Oct; 383(18):1706-1708. PubMed ID: 32931162
    [No Abstract]   [Full Text] [Related]  

  • 9. Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
    Slaoui M; Hepburn M
    N Engl J Med; 2020 Oct; 383(18):1701-1703. PubMed ID: 32846056
    [No Abstract]   [Full Text] [Related]  

  • 10. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Whitehead CL; Walker SP
    Lancet; 2020 May; 395(10237):e92. PubMed ID: 32410758
    [No Abstract]   [Full Text] [Related]  

  • 11. Underpromise, overdeliver.
    Thorp HH
    Science; 2020 Mar; 367(6485):1405. PubMed ID: 32205459
    [No Abstract]   [Full Text] [Related]  

  • 12. Ending COVID-19: progress and gaps in research-highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings.
    ;
    BMC Med; 2020 Oct; 18(1):342. PubMed ID: 33115460
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
    Avorn J; Kesselheim A
    JAMA; 2020 Oct; 324(13):1284-1285. PubMed ID: 32870268
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH organizes hunt for drugs.
    Kaiser J
    Science; 2020 Apr; 368(6489):351. PubMed ID: 32327575
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination prevention for COVID-19.
    Cohen MS; Corey L
    Science; 2020 May; 368(6491):551. PubMed ID: 32381692
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use.
    Edwards KM; Orenstein WA
    J Pediatr; 2020 Sep; 224():124-128. PubMed ID: 32565096
    [No Abstract]   [Full Text] [Related]  

  • 17. Fast-and-fit vaccines.
    Nat Biomed Eng; 2020 Aug; 4(8):757-758. PubMed ID: 32760006
    [No Abstract]   [Full Text] [Related]  

  • 18. G20 leaders must answer to COVID-19.
    Atkinson C
    Science; 2020 Apr; 368(6487):111. PubMed ID: 32273441
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
    Schwartz JL
    N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: The Need for Immunoprevention at Industrial Scale.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.